These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 55428)
21. Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities. Grammer LC; Shaughnessy MA; Finkle SM; Shaughnessy JJ; Patterson R J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):53-8. PubMed ID: 3944375 [TBL] [Abstract][Full Text] [Related]
22. [Antigenic properties of the allergoid from ragweed pollen]. Raĭkis BN; Ugrimov SA; Makhinovskaia FL; Illiutovich NA Biull Eksp Biol Med; 1980 Aug; 90(8):197-8. PubMed ID: 6773603 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release. Norman PS; Lichtenstein LM; Ishizaka K J Allergy Clin Immunol; 1973 Oct; 52(4):210-24. PubMed ID: 4126355 [No Abstract] [Full Text] [Related]
24. Evaluation and standardization of polymerized ragweed extracts by chromatography, radioimmunoassay inhibition, and end point cutaneous titration. Grammer LC; Silvestri L; Suszko IM; Shaughnessy MA; Patterson R J Allergy Clin Immunol; 1983 Aug; 72(2):160-7. PubMed ID: 6886254 [TBL] [Abstract][Full Text] [Related]
25. Potentiation of IgE-mediated cutaneous reactivity and blood leucocyte histamine release by deuterium oxide. Patterson R; Suszko IM; Harris KE Clin Exp Immunol; 1975 Feb; 19(2):335-42. PubMed ID: 55323 [TBL] [Abstract][Full Text] [Related]
26. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. Lichtenstein LM; Ishizaka K; Norman PS; Sobotka AK; Hill BM J Clin Invest; 1973 Feb; 52(2):472-82. PubMed ID: 4119162 [TBL] [Abstract][Full Text] [Related]
27. Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. Marsh DG; Norman PS; Roebber M; Lichtenstein LM J Allergy Clin Immunol; 1981 Dec; 68(6):449-59. PubMed ID: 6171586 [TBL] [Abstract][Full Text] [Related]
28. Stability of antigen E in commercially prepared ragweed pollen extracts. Center JG; Shuller N; Zeleznick LD Dev Biol Stand; 1975; 29():114-22. PubMed ID: 1149927 [TBL] [Abstract][Full Text] [Related]
29. The effect of immunotherapy on humoral and cellular responses in ragweed hayfever. Evans R; Pence H; Kaplan H; Rocklin RE J Clin Invest; 1976 May; 57(5):1378-85. PubMed ID: 57122 [TBL] [Abstract][Full Text] [Related]
30. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. Grammer LC; Zeiss CR; Suszko IM; Shaughnessy MA; Patterson R J Allergy Clin Immunol; 1982 Jun; 69(6):494-9. PubMed ID: 7042799 [TBL] [Abstract][Full Text] [Related]
31. Immunochemical and genetic studies of Amb.t. V (Ra5G), an Ra5 homologue from giant ragweed pollen. Roebber M; Klapper DG; Goodfriend L; Bias WB; Hsu SH; Marsh DG J Immunol; 1985 May; 134(5):3062-9. PubMed ID: 3856613 [TBL] [Abstract][Full Text] [Related]
32. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113 [TBL] [Abstract][Full Text] [Related]
33. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release. Pruzansky JJ; Grammer LC; Patterson R; Roberts M J Immunol; 1983 Oct; 131(4):1949-53. PubMed ID: 6194222 [TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators. Rocklin RE; Pence H; Kaplan H; Evans R J Clin Invest; 1974 Mar; 53(3):735-44. PubMed ID: 4130213 [TBL] [Abstract][Full Text] [Related]
35. A comparison of the immune response to immunotherapy with polymerized grass allergen and monomeric grass allergen. Fitzsimons R; Grammer LC; Shaughnessy MA; Patterson R Ann Allergy; 1986 Oct; 57(4):291-4. PubMed ID: 3767091 [TBL] [Abstract][Full Text] [Related]
36. Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines. Manzano AI; Javier Cañada F; Cases B; Sirvent S; Soria I; Palomares O; Fernández-Caldas E; Casanovas M; Jiménez-Barbero J; Subiza JL Glycoconj J; 2016 Feb; 33(1):93-101. PubMed ID: 26603537 [TBL] [Abstract][Full Text] [Related]
37. Allergen extracts and purified allergen in immunotherapy. Kwong FK Ann Allergy; 1981 Sep; 47(3):162-5. PubMed ID: 6168219 [No Abstract] [Full Text] [Related]
38. Immunogenic properties of modified antigen E. III. Effect of repeated injections of modified antigen on immunocompetent cells specific for native antigen. Takatsu K; Ishizaka K; King TP J Immunol; 1975 Dec; 115(6):1469-76. PubMed ID: 52668 [TBL] [Abstract][Full Text] [Related]
39. Polymerized ragweed antigen E. 3. Differences in immune response to three molecular weight ranges of monomer and polymer. Patterson R; Suszko IM J Immunol; 1974 May; 112(5):1855-60. PubMed ID: 4818462 [No Abstract] [Full Text] [Related]
40. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy. Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):87-94. PubMed ID: 1370511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]